Galafold 123 MG
Ended Awarded Last action
- Contract number
- 36C24526N0544
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $22,840
Award facts
- Contract value 100% obligated
- $22,839.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
Veterans Integrated Service Network 5 issued a $22,839.61 delivery order to Amicus Therapeutics US, LLC on April 28, 2026, under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule for Galafold 123 mg. Performance is at Philadelphia, PA, with an ultimate completion date of May 4, 2026.
The parent vehicle is the GSA Federal Supply Schedule contract (FSS-61-IB), a multiple-award schedule enabling VA networks nationwide to procure pharmaceutical products including enzyme replacement therapies. This order is priced on a firm fixed-price basis with no set-aside. Amicus Therapeutics US, LLC supplies Galafold (migalastat) 123 mg, an FDA-approved enzyme replacement therapy for Fabry disease treatment, directly as the prime contractor without subcontractor involvement.
Quick answers
Who was awarded contract 36C24526N0544?
36C24526N0544 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 28, 2026.
How much is contract 36C24526N0544 worth?
The government has obligated $22,840 on 36C24526N0544.
Is contract 36C24526N0544 an order under another contract?
Yes. 36C24526N0544 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0544 competed?
The extent of competition for 36C24526N0544 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award